Tamara Maes

Net worth: 5 M $ as of 2024-03-30

Health Technology

Consumer Services

Industrial Services

Profile

Tamara Maes is the founder of Oryzon Genomics SA, which was founded in 2000.
She currently holds the position of First Deputy Chairman at Oryzon Genomics SA. Dr. Maes is also currently working as a Director at Mendelion Lifesciences SL, a Member at the Alzheimers Drug Discovery Foundation, and a Scientific Coordinator at Oncnosis Pharma AIE.
Dr. Maes obtained a doctorate degree from Ghent University.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
ORYZON GENOMICS SA 4.08%	2022-12-30	2,528,398 ( 4.08% )	5 M $	2024-03-30

Tamara Maes active positions

Companies	Position	Start
ORYZON GENOMICS S.A.	Founder	2000-06-01
Oncnosis Pharma AIE	Corporate Officer/Principal	-
Mendelion Lifesciences SL Mendelion Lifesciences SL Engineering & ConstructionIndustrial Services Mendelion Lifesciences SL constructs commercial buildings.	Director/Board Member	-
Alzheimers Drug Discovery Foundation Alzheimers Drug Discovery Foundation BiotechnologyHealth Technology The Alzheimer's Drug Discovery Foundation (ADDF) is a public charity founded in 1998 by Ronald Steven Lauder, Leonard Alan Lauder, and Howard Fillit. The non-profit company is based in New York, NY. The ADDF is dedicated to accelerating the discovery of drugs to prevent, treat, and cure Alzheimer's disease. The company is the only public charity solely focused on funding the development of drugs for Alzheimer's, using a venture philanthropy model to support research in academia and the biotech industry. The ADDF has awarded over $209 million to fund over 690 Alzheimer's drug discovery programs, biomarker programs, and clinical trials in 19 countries. The CEO is Mark Roithmayr.	Corporate Officer/Principal	2015-12-31

All active positions of Tamara Maes

Training of Tamara Maes

Ghent University

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Tamara Maes's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
ORYZON GENOMICS S.A.	Health Technology

Private companies	3
Alzheimers Drug Discovery Foundation Alzheimers Drug Discovery Foundation BiotechnologyHealth Technology The Alzheimer's Drug Discovery Foundation (ADDF) is a public charity founded in 1998 by Ronald Steven Lauder, Leonard Alan Lauder, and Howard Fillit. The non-profit company is based in New York, NY. The ADDF is dedicated to accelerating the discovery of drugs to prevent, treat, and cure Alzheimer's disease. The company is the only public charity solely focused on funding the development of drugs for Alzheimer's, using a venture philanthropy model to support research in academia and the biotech industry. The ADDF has awarded over $209 million to fund over 690 Alzheimer's drug discovery programs, biomarker programs, and clinical trials in 19 countries. The CEO is Mark Roithmayr.	Health Technology
Oncnosis Pharma AIE
Mendelion Lifesciences SL Mendelion Lifesciences SL Engineering & ConstructionIndustrial Services Mendelion Lifesciences SL constructs commercial buildings.	Industrial Services

See company connections